Harvard Bioscience (HBIO) Tops Q3 EPS by 2c

July 26, 2018 4:29 PM EDT

Harvard Bioscience (NASDAQ: HBIO) reported Q3 EPS of $0.07, $0.02 better than the analyst estimate of $0.05. Revenue for the quarter came in at $31.5 million versus the consensus estimate of $30.66 million.

For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings